U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06860555) titled 'Hyperspectral Drusen Classification' on Feb. 28.
Brief Summary: This observational, cross-sectional study is designed to explore the feasibility to extract spatial-spectral features from hyperspectral retinal images captured with Optina Diagnostics' MHRC that are characteristic to the different types of drusenoid deposits associated with dry age-related macular degeneration.
Study Start Date: Nov. 08, 2022
Study Type: OBSERVATIONAL
Condition:
Dry Age Related Macular Degeneration
Intervention:
DEVICE: Mydriatic Hyperspectral retinal Camera, (MHRC) and Optical coherence tomography (OCT)
Imaging with the MHRC and optical coheren...